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Abstract
Objectives: The aim of the present study was to investigate the analgesic and anti-inflammatory effects of dexketoprofen 
trometamol (DT) and paracetamol on deep acute somatic pain and inflammation in patients undergoing impacted third 
molar surgery. This study was planned to present benefits that we could obtain with low burden of drug.
Study Design: Effects of drugs, which were administered preemptively before the procedure, on pain, mouth-
opening limitation, and swelling were assessed by visual analogue scale (VAS), magnetic resonance imaging 
(MRI), and mouth-opening measurement. Following surgery, time intervals when the patients first need to receive 
the drug were measured.
Results: The VAS scores of the patients were lower in the side treated with DT than that in the paracetamol treated 
side. There was no significant difference between the groups in terms of mouth-opening limitation. MRI record-
ings revealed that swelling was lower in the side treated with paracetamol than DT treated side.
Conclusions: Administration of the drugs before surgery contributed to the postoperative patient comfort. The 
analgesic activity of 12.5 mg dose of DT was similar to, even better than, the analgesic activity of 500 mg dose of 
paracetamol; however, DT had insufficient anti-inflammatory efficacy.
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Introduction
Dexketoprofen trometamol (DT), which has been in 
clinical use since 1996, is the water-soluble salt of dex-
trorotatory enantiomer of racemic ketoprofen, a non-
steroidal anti-inflammatory drug (NSAID) (1). Since 
dexketoprofen is more lipophilic than ketoprofen, it is 
rapidly absorbed, its activity starts in a short time and 
it reaches to maximum plasma concentration in a short 
period (2,3). Dexketoprofen presents its peripheral ac-
tivity directly on the lesion area and central activity 
directly on the central nervous system (4,5). Likewise 
other NSAIDs, antipyretic, anti-inflammatory, and 
analgesic mechanisms of action of dexketoprofen are 
based on the inhibition of prostaglandin synthesis. 
Paracetamol is a non-opioid analgesic preferred in mild-
to-moderate pain due to its weak inhibition effect on 
prostaglandin synthesis, although its mechanism of ac-
tion is not clearly defined. Despite its short half-life, 
in addition to its solitary usage as an analgesic, para-
cetamol is used to support NSAIDs or as an alternative 
option where NSAIDs are contraindicated in history 
of hypersensitivity, bleeding and gastrointestinal ulcer 
(6). Its anti-inflammatory property is rarely mentioned 
while listing all these properties.
The present study including healthy volunteers with bi-
lateral impacted mandibular third molars investigated 
the efficacy of drugs, which belong to two different drug 
classes (propionic acid class of NSAIDs and para-ami-
nophenol derivative, non-opioid), during the inflamma-
tory process expected to occur following the extraction 
of impacted wisdom tooth in the same individual. The 
right or left impacted wisdom teeth of the patients were 
randomly allocated into DT and paracetamol groups. 
DT and paracetamol were commenced before the opera-
tion at doses of 12.5 mg and 500 mg, respectively, those 
do not cause adverse effects, and continued after the op-
eration in order to evaluate whether they were effective 
on acute deep somatic pain, swelling, and trismus.
Material and Methods
In the present prospective study, 21 outpatients between 
18 and 35 years of age who had bilateral impacted lower 
third molars requiring removal of alveolar bone for ex-
traction and were admitted to the Department of Oral 
and Maxillofacial Surgery of Selcuk University Faculty 
of Dentistry were enrolled. The study protocol was ap-
proved by the Research and Ethics Committee of the 
Faculty of Dentistry and the informed consents were 
obtained. 
The study population was composed of healthy volun-
teers having no systemic disease or available for MRI 
evaluation. In clinical and radiological examinations, it 
was paid attention that right and left mandibular wis-
dom tooth symmetrically be in the same angulation 
and impacted with the same depth. The right or left 
impacted wisdom teeth of the patients were randomly 
allocated into DT and paracetamol groups; there was no 
placebo group. In the early preoperative period, the pa-
tients received a single initial dose of either 12.5 mg DT 
or 500 mg paracetamol one hour before the operation. 
Each patient received both of the treatments in random 
order and they were operated by the same surgeon. In 
all surgical interventions, mucoperiosteal flap and oste-
otomy were performed. For maintenance of anesthesia, 
4% articaine HCl with 1:100,000 epinephrine was used. 
Surgery was performed twice for each patient, at first, 
one impacted tooth was removed and two weeks later, 
in case no symptoms arose from the first surgical proce-
dure, other impacted tooth was removed.
After the operation, all patients were administered 625 
mg dose of amoxicillin/clavulanic acid two times a day 
for five days and chlorhexidine mouthwash two times a 
day for seven days. We prescribed prophylactic antibiot-
ics for our patients against the risk of infection. In case 
of postoperative pain, patients were asked to receive the 
preoperative doses of the same drugs (500 mg paraceta-
mol or 12.5 mg DT) for every 8 hours. Each patient was 
informed about how to measure pain intensity on a VAS 
ranging from 0 to 10; 0 represented no pain and 10 rep-
resented the worst pain imaginable. The patients were 
asked to receive the same drug whenever moderate or 
severe pain (score ≥4 on VAS) arose after the surgery 
and to record the dosing time and VAS score at that time 
on the recording form for 24 hours. Study investigator 
collected the forms on the 2nd postoperative day after 
the 1st postoperative clinical control was performed.
Maximum mouth opening was measured by a vernier-
calibrated sliding caliper preoperatively and on the 2nd 
and 7th postoperative days in order to assess trismus. 
Trismus on the 2nd and 7th postoperative days was as-
sessed based on the following calculations: 1) preop-
erative maximum mouth opening - 2nd postoperative 
day maximum mouth opening = 2nd postoperative day 
trismus value, 2) preoperative maximum mouth open-
ing - 7th postoperative day maximum mouth opening = 
7th postoperative day trismus value.
Swelling was evaluated by magnetic resonance imaging 
(MRI). All examinations were performed by the same 
radiologist in the Department of Radiology of Konya 
Necmettin Erbakan University Meram Faculty of Medi-
cine. Each patient was evaluated in the preoperative 
period and on the 2nd postoperative day. MRI records 
were obtained at a workstation program using 1.5 Tesla, 
Picker PQS (Picker Edge, Cleveland, Ohio, USA) with 
a head coil. Images were obtained by an axial spin-
echo T1-weighted sequence with 5-mm slice thickness. 
Slices were taken parallel to the occlusal plane and 
perpendicular to the mandibular alveolar process. The 
distance between the mandibular alveolar process-skin 
was measured.
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Data were analyzed using the statistical package for the 
social sciences (SPSS Inc., Chicago, IL, USA) version 
7.5. The independent Student’s t-test was used to com-
pare data between the two study drug groups. A p value 
<0.05 was considered statistically significant.
Results
In the present study, 6 out of 21 outpatients were exclud-
ed from the study, of whom 2 did not undergo the sec-
ond scheduled surgery, 2 had insufficient MRI results, 
and 2 did not comply with the drug regimen. Thus, the 
remaining 15 patients were included in the analysis. The 
mean age of the patients was 22.8±1.41 years and the 
male-to-female ratio was 1:2. All the values and meas-
urements (VAS scores, swelling, and trismus values) for 
each patient are presented in table 1.
Time to the first need for drug after the surgery were in-
creased in both groups and the most noted time interval 
on the forms was the 5th and 6th hour interval after the 
first use of drug. Only 1 patient noted the 3rd and 4th 
hour interval.
There were no significant differences between the two 
groups in terms of the postoperative VAS scores of 8th, 
16th and 24th hours (p=0.006, p=0.452, p=0.607, re-
spectively). However, in the DT group, analgesia was 
more effective at a rate of 33%, 22%, and 21% on the 
8th, 16th, and 24th hours, respectively as compared to 
those in the paracetamol group.
Left-right sides VAS 
8th hour
VAS 
16th hour
VAS 
24th hour
Trismus 
2nd Postop day
Trismus 
7th Postop day
Swelling
Patient number Paracetamol Group
1 36 4 2 8 2 10.6
2 28 0 14 6 2 7.3
3 80 0 15 28 4 8.7
4 45 26 20 16 0 5.8
5 27 28 0 20 15 10.5
6 82 53 24 24 4 9.8
7 90 28 0 10 0 8.3
8 52 80 11 14 7 2.8
9 24 21 10 24 4 5.6
10 66 42 25 17 0 7.8
11 36 19 0 10 1 2.5
12 32 24 21 7 0 5.4
13 47 87 63 20 17 7.7
14 42 0 10 13 5 5.7
15 44 28 13 12 0 3.1
Patient number Dexketoprofen Trometamol Group
1 53 25 4 9 1 4.9
2 21 0 3 2 0 5
3 6 0 0 14 2 8
4 19 10 5 5 0 9.1
5 17 32 21 14 2 9.9
6 51 24 15 18 14 12.1
7 55 13 0 7 4 9.5
8 32 43 4 15 1 8.9
9 20 11 6 12 4 8.7
10 71 40 22 16 8 12.3
11 15 35 0 10 2 6
12 22 0 0 1 0 6.7
13 51 62 70 18 15 11.4
14 50 37 20 13 4 7.3
15 31 12 10 8 0 11.6
Table 1. All values and measurements (VAS scores, swelling, and trismus values) for each patient.
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In the evaluation of swelling between the groups in 
terms of preoperative and postoperative measurements, 
the values in the DT group were significantly higher on 
the 2nd postoperative day than that in the paracetamol 
group. The paracetamol group demonstrated a 22% 
lower rate of swelling than the DT group.
The patients in the DT group had less trismus values 
than those in the paracetamol group on the 2nd and 7th 
postoperative days, although statistically not significant 
(p=0.56 and p=0.887, respectively). While the patients 
in the paracetamol group presented better trismus val-
ues than DT group by 29% on the 2nd postoperative 
day, the difference was only 7% on the 7th postopera-
tive day. In both drug groups, the mean trismus values 
of males were significantly lower than those of the fe-
males (p=0.001 for both). The study results are sum-
marized in table 2.
Groups Pain Intensity Facial 
Swelling 
LMOD
8th hour 16th hour 24th hour  2nd Postop 
Day
7th Postop 
Day
Paracetamol 
(n=15) 
4.87±2.12 2.93±2.68 1.52±1.57 6.77±2.65* 15.25±6.78 4.07±5.32 
DT (n=15) 3.42±1.92 2.29±1.86 1.20±1.79 8.76±2.45* 10.80±5.40 3.80±4.86 
Male (n=10) 3.76±2.32 1.66±1.68 1.02±0.94 6.69±2.42 7.70±4.55* 0.50±0.85* 
Female (n=20) 4.40±2.00 3.24±2.45 1.58±2.00 8.30±2.74 15.70±5.56* 5.65±5.35* 
Table 2. Pain intensity, facial swelling, and limited mouth opening difference measurements of patients according to the study groups 
and gender.
Data are presented as mean±standard deviation.
*p<0.05
Discussion
Severity of the inflammatory response may vary even 
the reason for local tissue damage in the extraction of 
impacted wisdom tooth is similar for every patient (7). 
It has been suggested that administering the drug be-
fore procedure alleviates the inflammatory process and 
reduces the sequelae of tissue trauma and particularly 
pain (8). With regard to the suppression of inflammato-
ry process in particular, presence of drug in the metabo-
lism during the procedure would decrease the number 
of mediators likely to be released from the tissue in the 
surgical field.
Researches concerning bone surgery have proven that 
DT, which is considered to be a good pain reliever, rein-
forces anesthetic block and reduces need for postopera-
tive analgesic and morphine when administered before 
the procedure (9). In the present study as well, adminis-
tration of analgesic before the procedure prolonged the 
post-procedure pain-free period and the postoperative 
initial doses of both analgesics were received later than 
expected. When we considered the mean duration of 
local anesthesia as 3-3.5 hours based on the anesthetic 
agent used, time of the earliest drug use was recorded 
between the postoperative 5th and 6th hours. A study 
comparing the postoperative single doses of NSAIDs 
reported analgesic efficacy similar to that in the present 
study but with 25 mg and 50 mg doses of DT (10).
In non-surgical pain such as dental pain, dysmenorrhea, 
headache, and pain of musculoskeletal disorders, DT 
has been emphasized that it is safe in oral treatments 
and may be the first choice for therapeutic indications 
among 9 different drugs when compared with paraceta-
mol-metamizole control groups (11). However, in ad-
dition to overall prospectus information and research 
results, the most important thing to be considered about 
DT is the fact that patients with hepatic impairment can 
tolerate DT at a single daily dose of 25 mg, whereas 
patients with mild-to-moderate renal insufficiency can 
tolerate DT at a single daily dose of 12.5 mg (12,13). For 
this reason, the outcomes of 12.5 mg DT were investi-
gated in the present study.
In postoperative dental pain, comparison of 12.5 mg 
and 25 mg doses of DT with 575 mg dose of dipyrone 
revealed that DT had more analgesic efficacy than dipy-
rone even at a dose of 12.5 mg (14). In the present study, 
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12.5 mg of DT provided a better analgesic effect than 
500 mg of paracetamol according to the VAS scores of 
the patients, particularly in the first 8th hour after the 
surgery in which the pain level was expected to be the 
highest. Studies have mostly stressed on the pain re-
liever property of DT rather than its anti-inflammatory 
property. Only a single study which was performed fol-
lowing the extraction of impacted wisdom teeth com-
pared the anti-inflammatory activity of DT with that 
of another NSAID; however, the most remarkable im-
provable point of this study was that the evaluation of 
inflammation was not presented according to an objec-
tive criterion (15). In the present study, determination 
of the amount of swelling by MRI and measurement of 
mouth-opening limitation provided more objective data 
to evaluate anti-inflammatory effect of DT. In addition 
to any side effects of NSAIDs, photo-contact dermati-
tis, neutropenia, thrombocytopenia, liver injury (after 
10 days use), acute renal injury, and rhabdomyolysis (a 
single dose of 25 mg received for cold) have been re-
ported in the literature as side the effects of DT (16-18). 
In the present study, higher amount of bleeding on the 
DT side as compared to the paracetamol side was ob-
served during and after the surgery. However, further 
studies comparing DT with another NSAID in the same 
patients may provide more accurate results on whether 
DT enhances the bleeding.
In the present study, DT administered at low doses to 
avoid side effects was compared with paracetamol in 
terms of clinical outcomes. Better results were obtained 
in the VAS scores, in the number analgesics received 
postoperatively and in the pain-free interval by 12.5 
mg dose of DT than 500 mg dose of paracetamol. How-
ever, 12.5 mg dose of DT was found to be ineffective 
on swelling as compared to paracetamol, while there 
was no significant difference between the groups in 
terms of trismus. There are also studies in which anti-
inflammatory efficacy of paracetamol has been clini-
cally compared and found to be better than, or equal to, 
that of NSAIDs. It has been reported that indomethacin, 
a NSAID, and acetaminophen/codeine have equally 
reduced the complications such as pain and swelling 
developed after the impacted third molar surgery (19). 
In another study, naproxen 500 mg b.i.d. and acetami-
nophen 1000 mg q.i.d. were administered to the patients 
after the third molar surgery, and swelling was observed 
comparatively less by 22.4% with acetaminophen on 
the postoperative 3rd day (20). In the other study from 
the same authors, paracetamol 1000 mg q.i.d. and ibu-
profen 600 mg q.i.d. presented no significant difference 
in swelling after three days of administration; however, 
paracetamol was found to be more successful by 1.8% 
on the postoperative 3rd day (21). However, since anti-
inflammatory efficacy of paracetamol is quite low, it is 
not considered among NSAIDs. Under the light of these 
information, the question to be asked is whether para-
cetamol is a more potent anti-inflammatory drug than 
some NSAIDs or this group of drugs has a mechanism 
that could lead to swelling. Considering that the clas-
sification of NSAIDs have been performed based on the 
likely response to an irritating substance on animals, 
to what extend the NSAIDs present efficacy in human 
body can be exposed by only such type of studies (20).
The present study revealed that the values of female 
patients were higher than those of male patients. While 
some of these values were statistically significant, some 
were only clinically significant. Although it has been de-
fended that gender has an effect on swelling (22), it would 
be better to determine its role with further studies that 
would be performed in higher number of individuals. 
Since pain is an expected process after extraction of 
impacted wisdom tooth, the present study did not com-
prise a placebo group. We assessed paracetamol, which 
was frequently used in clinical practice and considered 
both safe and sufficient for postoperative pain, as the 
control group. Each patient received both of the drugs to 
avoid personal differences in response. Surgeries were 
performed rapidly by a single experienced surgeon. Pa-
tients were monitored for the first 24 and 48 hours dur-
ing which the pain and swelling were at the maximum 
level. Results were evaluated over objective criteria. In 
conclusion, the outcome of the present study revealed 
that DT, which was preemptively administered before 
surgery at safety dose limits according to the literature, 
had weak anti-inflammatory but adequate analgesic ef-
fects; however, paracetamol was both safe and satisfac-
tory with regard to clinical outcomes.
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